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ABSTRACT
Background: Evidence suggests a role for elevated serum calcium in dysregulated glucose
metabolism, linked through low-level chronic inflammation.
Objectives: We investigated the association of elevated serum calcium concentrations (corrected
for albumin) with markers of dysregulated glucose metabolism and type II diabetes and tested if
these associations were accounted for by chronic inflammation in a rural Indian population.
Methods: A cross-sectional analysis of participants aged 40–84 y from the Andhra Pradesh
Children and Parents Study (APCaPS; n = 2699, 52.2% women) was conducted. Comprehensive
information on household, sociodemographic, and lifestyle factors; medical and family history;
physical measurements; blood measurements including fasting plasma glucose (FPG), fasting
insulin (FI), serum calcium, albumin, phosphorous, vitamin D (in a subset), and creatinine were
analyzed. Additionally, in a random sample of healthy participants (n = 1000), inflammatory
biomarkers (interleukins 6 and 18, soluble intercellular adhesion molecule 1, adiponectin, and
high-sensitivity C-reactive protein) were measured and an inflammatory score (IScore) calculated.
Results: After adjustments for sociodemographics, lifestyle factors, and anthropometry the
highest calcium quartile (Q4 compared with Q1) was associated with FI (β = 1.4 µU/ml; 95% CI:
1.2, 1.5 µU/ml; P-trend < 0.001), the homeostasis model assessment for insulin resistance
(HOMA-IR) (β = 1.4; 95% CI: 1.2, 1.5; P-trend < 0.001), and was modestly associated with FPG
(β = 2.1 mg/dL; 95% CI: −0.9, 5.2 mg/dL; P-trend = 0.058) and prevalent type II diabetes
(OR = 1.6; 95% CI: 1.0, 2.6; P-trend= 0.020). In the healthy subgroup, the association of the
highest calcium quartile was similar for FI and HOMA-IR. Additional adjustment with IScore did
not alter the associations. Further, in a subset, all these associations were independent of
endogenous regulators of calcium metabolism (serum vitamin D, phosphorus, and creatinine).
Independently, after accounting for potential confounders, the highest IScore quartile (Q4
compared with Q1) was positively associated with FPG, FI, HOMA-IR, and prevalent prediabetes,
and also with serum calcium concentrations in men.
Conclusions: Elevated serum calcium was positively associated with markers of dysregulated
glucose metabolism and prevalent type II diabetes in a rural Indian population. Chronic
inflammation did not mediate this association but was independently associated with markers of
dysregulated glucose metabolism. Inflammation might be responsible for elevated serum
calcium concentrations in men. Curr Dev Nutr 2019;3:nzy085.
;
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Introduction
Type II diabetes is one of the leading causes of morbidity and mortality
due to a noncommunicable disease globally (1–3). Over the past decade,
although major noncommunicable diseases including cardiovascular
disease (CVD) and chronic obstructive respiratory disease (COPD)
have either increased modestly or notably declined in some geographic
regions, diabetes has increased globally [relative increase from 2006
to 2016: 24.4%; 95% CI: 22.7%, 26.2%) in disability-adjusted life-years
(DALYs) and 31.1% (95% CI: 28.9%, 33.4%) in absolute deaths] (1–3).
The estimated 1.4 million deaths and over 570 million DALYs due to
diabetes in 2016 are also likely underestimates (1, 2). Asia, with the
most populous countries of the world (i.e., China and India), is at the
epicenter of this burden, although the pattern of disease differs from
that found in the West (3), and novel etiopathologic explorations are
therefore imperative for planning effective preventive and therapeutic
strategies (3, 4).
Calcium modulates enzymatic functions in the liver that are
responsible for the production of glucose and the breakdown of
glycogen. Calcium concentrations in blood and tissues are vital for
secretion of insulin by the β cells of the pancreas (4). Thus, glucose
production and β cell function are calcium dependent, and calcium
homeostasis in blood and tissues is important for the control of glucose
metabolism (4). Elevated serum calcium concentrations have been
associated with an increased risk of type II diabetes in longitudinal
studies (5–8) independent of potential confounders including adiposity
and endogenous regulators of calcium metabolism such as vitamin D,
phosphorus, parathyroid hormone (PTH), or renal function (9). Fur-
ther, cross-sectional studies (10–13) have shown positive associations
of elevated serum calcium concentrations with markers of dysregulated
glucose metabolism, such as increased levels of fasting glucose, glucose
intolerance, insulin resistance, and defective β cell function, as well as
type II diabetes.
Chronic low levels of inflammation triggered by energy excess
constitute an important biological mechanism which may be asso-
ciated with elevated serum calcium concentrations (4) and mediate
the association of calcium with dysregulated glucose metabolism
(4, 14). However, given the complexity of endogenous (vitamin D,
renal function, hormones) and exogenous regulators (dietary intake,
supplements, medications such as diuretics) of calcium metabolism
(15), testing these associations in different settings and populations
(9) and understanding the potential biological mechanism underlying
the associations are vital (15). Data from rural Indian adults, with a
different pattern of type II diabetes (3, 16) and distinctive risk exposures
such as tobacco chewing, regional dietary patterns, possible infectious
history, and genetics, provide the opportunity to assess the relationship
between calcium, inflammation, and glucose metabolism within a
different structure of confounders compared with the populations
more often studied. The Andhra Pradesh Children and Parents Study
(APCaPS) is a prospective birth cohort study with data collected
from rural Indian adolescents and adults at 3 time points (2003–
05, 2009–10, 2011–12) (17). We evaluated the association of serum
calcium concentrations with levels of fasting plasma glucose (FPG),
fasting insulin (FI), HOMA-IR and the prevalence of prediabetes (FPG
100–125 mg/dL) and type II diabetes (doctor-diagnosed plus FPG
≥126 mg/dL) in rural Indian adults aged ≥40 y based on the data from
the 2011–12 collection round. We included additional inflammatory
data in a subset of healthy participants to test if these associations were
partly or fully accounted for by chronic inflammation after excluding
participants with self-reported history of any chronic disease including
hypertension, diabetes, CVD, COPD, and cancer.
Methods
The analyses in this study used data from the third follow-up of
APCaPS (2010–12), a prospective cohort study established through
long-term follow-up of the Hyderabad Nutrition Trial (1987–90). Brief
details of the study design are included as Supplemental Material
along with a participant flow chart and venn diagram (Supplemental
Figure 1-2). A total of 6944 out of a potential 10,213 individuals
participated during this phase. This included adults born between 1987
and 1990, their parents, and householdmembers. Our analysis included
men and women aged ≥40 y (n = 2699) from the third follow-up
phase. Comprehensive information on household, sociodemographic,
socioeconomic, lifestyle factors, medical and family history, as well
as physical measurements (anthropometrics and blood pressure) were
collected. Fasting blood samples (8 h) were collected, and biochemical
concentrations of FPG and FI, and serum concentrations of nutrients
including calcium, phosphorus as well as vitamin D in a subset
(n = 1713), along with full blood count, and kidney function tests
(e.g., serum creatinine, albumin) were measured. Vitamin D data were
available for adults born between 1987 and 1990 and their parents
(n = 1713/2699), but were not available for other members of the
household or community. Inflammatory biomarkers IL-6, IL-18, soluble
intercellular adhesion molecule 1 (sICAM-1), adiponectin, and high-
sensitivity C-reactive protein (hsCRP) and weremeasured in a subset of
randomly selected healthy participants aged≥40 y (n= 1000) excluding
participants with self-reported history of any chronic disease including
hypertension, diabetes, CVD, COPD, and cancer.
Data collection
Questionnaire data.
Structured interviewer-administered questionnaires were used to col-
lect data from all participants between January 2010 and December
2012. Comprehensive data on sociodemographics, socioeconomics,
and lifestyle factors were collected. The study participants lived in
rural locations with gradual improvements in existing facilities and
infrastructure over the course of the study period (2003–2012). This
degree of urbanization was calculated through the use of a composite
urbanization score, and the participants were classified into tertiles. A
subset of questions (14/29) from the National Health Family Survey-2
(18) was used to estimate socioeconomic position based on information
about the the quality of housing, toilet facilities, source of lighting,
drinking water, household articles, and agricultural land. A Standard
of Living Index (SLI) was derived based on these estimates.
Clinical assessments.
Weight was measured to the nearest 0.1 kg with a digital balance (SECA
899), and standing height measured to the nearest 1 mm with a plastic
stadiometer (Leicester heightmeasure; Chasmors).Measurements were
taken twice and the average of 2 values was used in the analysis. BMI
was calculated as weight (kg)/height (m2). Systolic and diastolic blood
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pressure was measured with a validated oscillometric device (Omron
M5-I; Matsusaka Co.) in the supine position, with appropriate cuff
sizes. Each measure was taken 3 times and the average used. Physical
activity level (PAL) was assessed based on metabolic equivalent tasks
(19) (see Supplementary Material for details). Hypertension included
doctor-diagnosed disease, a systolic blood pressure ≥140 mm Hg or
a diastolic blood pressure ≥90 mm Hg at the time of the interview.
Diabetes included doctor-diagnosed disease or an FPG >126 mg/dL at
the time of the interview. Prediabetes included an FPG 100–125 mg/dL
at the time of the interview.
Biochemical measurements.
Participants attended morning clinics and were asked to fast overnight.
Venous blood samples (20 mL) were drawn in plain and fluoride
vacutainers (Becton & Dickinson) by a trained phlebotomist, the
samples were centrifuged at 800 × g for 15 min at 22-25°C, and
transferred to the laboratory on ice. All assays, except for FPG and
vitamin D (measured at the National Institute of Nutrition, Hyderabad,
India), were performed in the Genetics and Biochemistry Laboratory of
the South Asia Network for Chronic Disease, Public Health Foundation
of India, New Delhi. FPG was analyzed by an enzymatic method
based on the use of glucose oxidase/peroxidase-4- aminophenazone-
phenol on the same day, and the remaining serum samples were stored
at −80°C for further analysis; FI was determined by electrochemi-
luminescence immunoassay based on the sandwich principle with
the use of a Roche Diagnostics Cobas 411 autoanalyzer and Roche
reagents; albumin was measure by the bromocresol green method and
creatinine by Jaffe’s method, rate blanked and compensated. Serum
calciumwas estimated with o-cresolphthalein complex 1 under alkaline
conditions. Total serum calcium was corrected for albumin through
the use of the formula: (serum calcium mg/dL) + [0.8 × (4 –
serum albumin g/dL)]. Inorganic phosphate was measured through
formation of the ammonium phosphomolybdenum complex; vitamin
D was measured by quantitative HPLC and detected at 265 nm with
a UV detector (CV 7%). hsCRP was measured by a particle-enhanced
immunoturbidimetry method, IL-6, IL-18, and sICAM-1 were assayed
by ELISA, (Krishgen BioSystems), and adiponectin was assayed by a
sandwich assay that used kits from Mediagnost, Diagnostika GmbH.
The intra-assay and interassay CV were at <3% and <5%, respectively.
HOMA-IR was calculated from the formula [(fasting glucose mg/dL
× fasting insulin µU/ml)/405] if fasting insulin was not equal to −1
µU/ml (20). Chronic inflammation was assessed through calculation of
a standardized composite inflammatory score (IScore) by summing the
z scores of markers as follows: [(z score IL-6) + (z score hsCRP) + (z
score IL-18)+ (z score sICAM-1)] – (z score adiponectin) as previously
described in Tabung et al. (21) with the exception of TNF-α (a
proinflammatory marker) which was not available. Participants were
categorized as anti- or proinflammatory based on negative and positive
IScores, respectively, as described by Tabung et al. (21).
Ethical approval
The study received approvals from the ethics committees of the
National Institute of Nutrition, the Indian Council ofMedical Research,
Hyderabad, India (latest approval 03/CR/2011/IV, dated 23 December
2011) and the London School of Hygiene and Tropical Medicine,
London, UK (latest approval LSHTM ethics ref: 6471, dated 29 July
2013). Approval was also sought from the village heads and their
committees in each of the 29 villages. The participants provided written
informed consent, or a witnessed thumbprint if illiterate, before their
inclusion in the study. This analysis received ethical approval from
the London School of Hygiene and Tropical Medicine, London, UK
(LSHTMMSc ethics ref: 12242, dated 16 June 2017) and Public Health
Foundation of India, Gurugram, Haryana, India (TRC-IEC-349/17,
dated 10 July 2017).
Statistical methods
All data are presented as mean± SD, median (IQR), or as numbers (%).
The levels of outcome variables (FPG, FI, HOMA-IR, and IScore) were
continuous. Corrected serum calcium concentrations were grouped in
quartiles. Bivariate comparisons for differences in means, proportions
or medians of sociodemographics, lifestyle factors, anthropometrics
and biochemical parameters based on gender (men compared with
women), and different quartiles of calcium concentrations (Q1–Q4)
were made with the use of appropriate tests of significance (t test,
ANOVA, chi-square test, Wilcoxon rank-sum test, and Kruskal-Wallis
ANOVA as per data type). As the data were correlated at household
level, multilevel random-effects regression models (linear or logistic)
accounting for household clustering were conducted to investigate the
association of calcium quartiles with FPG, FI, HOMA-IR, prevalent
prediabetes, and type II diabetes after adjusting for sociodemographics
[age (years), gender (men/women), degree of urbanization (tertiles)],
SLI tertiles, lifestyle factors [tobacco (never/ever), alcohol (never, daily-
weekly-monthly, or on special occasions), physical activity (categories
based on PALs as extremely inactive, sedentary, moderately active,
and vigorously active)], anthropometrics [BMI (kg/m2), waist circum-
ference (cm)] as well as endogenous regulators of serum calcium
concentrations such as serum phosphorus (mg/dL), serum creatinine
(mg/dL), and vitamin D (ng/ml) in a subset. Evidence of statistical
interactions was assessed by the log-likelihood ratio test of models
with and without the interaction terms. We also conducted sensitivity
analysis by excluding participants who used any antihypertensive
medications. Missing data for different variables were <5% and were
excluded from the analysis. To assess if observed effects might be
mediated through chronic inflammation, we used the approach of
Baron andKenny (22, 23)Thiswas done in a randomsample of a healthy
subgroup of participants. Multilevel random-effects models for the
associations of corrected serum calcium concentrations with FPG, FI,
HOMA-IR, and prevalent prediabetes were conductedwith andwithout
adjustments for IScore. Further, independent associations of IScore
with corrected serum calcium concentrations, FPG, FI, HOMA-IR, and
prevalent prediabeteswere also tested. All analyseswere performedwith
STATASoftware, version 10.1 (Stata Corp.), and themultilevel sampling
scheme was reflected in all of the analyses.
Results
Associations of serum calcium concentrations with markers
of dysregulated glucose metabolism and prevalent type II
diabetes
The analysis included 2699 APCaPS participants aged 50.3 ± 7.0
y (range: 40–84 y); 52.2% were women. For the whole population,
86.1% were village dwellers, most with no formal education (85.7%).
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One-fourth of the participants were current tobacco users (24.9%);
21.5% consumed alcohol regularly; 98.4% ate a nonvegetarian diet; and
50.9% reported a sedentary lifestyle. Median corrected serum calcium
was 9.3 mg/dL (IQR: 8.9, 9.7 mg/dL), mean phosphorus was 4.1 ±
0.8 mg/dL and mean vitamin-D was 20.0 ± 9.1 ng/mL (data available
for a subset of participants; n = 1713). These characteristics stratified
by sex are shown in Table 1. Although serum calcium concentrations
were not different between men and women, there were significant
differences in serum concentrations of phosphorus, vitamin D, and
creatinine, as well as fasting insulin. Baseline characteristics stratified
by quartiles of corrected serum calcium concentrations are presented in
Table 2. Overall, participants in the highest quartile tended to be living
in locations with a higher urbanization score and had higher serum
phosphorus, creatinine, fasting glucose, fasting insulin, and insulin
resistance, as well as prevalent type II diabetes.
Multivariable adjusted results for the association of corrected serum
calcium quartiles with markers of glucose metabolism, prevalent
prediabetes and type II diabetes are presented in Table 3. After adjust-
ments for demographic, lifestyle, and anthropometric characteristics,
participants in the highest calcium quartile were more likely to have
higher levels of FI and HOMA-IR with a modest increase in FPG
and prevalence of type II diabetes than those in the lowest quartile
(Q4 compared with Q1) (FI: β = 1.4, 95% CI: 1.2, 1.5 µU/ml,
P-trend < 0.001; HOMA-IR: β = 1.4, 95% CI: 1.2, 1.5, P-trend
< 0.001; FPG β = 2.1, 95% CI: −0.9, 5.2, P-trend = 0.058 and
prevalent type II diabetes OR: 1.6, 95% CI: 1.0, 2.6, P-trend = 0.020).
There was no association of serum calcium with prevalent prediabetes,
and there were no significant interactions in associations between
serum calcium and the outcomes by sex. We conducted 2 sensitivity
analyses. In the first of these analyses, which used the subset with the
vitamin D data (n = 1713), a similar pattern as whole population was
found, but with slightly stronger associations, including when adjusting
for serum concentrations of vitamin D, phosphorus, and creatinine
(Supplemental Table 1).The vitaminD subset comprised youngermen
and women with lower SLI than the participants for whom vitamin
D data was not available (data not shown). In the second sensitivity
analyses we excluded participants who regularly used any hypertensive
medication (n = 188). Again, the results were similar, although slightly
attenuated (Supplemental Table 1).
Mediation of chronic inflammation in associations between
serum calcium and markers of dysregulated glucose
metabolism in a healthy subset of participants
The characteristics of the healthy subset of participants (n= 1000) with
inflammatory markers assessed were similar to the whole population
and are shown stratified by sex in Supplementary Table 2. Men had a
higher inflammatory score (IScore) than women (mean IScore: 0.2 ±
2.4 compared with −0.3 ± 2.2 in women). Men had higher amounts
of IL-18 but lower IL-6 and adiponectin than women (P < 0.001).
Although there were no differences in serum calcium concentrations
between men and women, the concentrations of serum phosphorus,
vitamin D, and fasting insulin, as well as the insulin resistance differed
(Supplementary Table 2). Within the healthy subset, after adjustment
for demographic characteristics, lifestyle factors and anthropometrics,
the highest corrected serum calcium quartile was positively associated
with FI (β = 1.3, 95% CI: 1.2, 1.5, P-trend < 0.001) and HOMA-
IR (β = 1.3, 95% CI: 1.1, 1.5, P-trend < 0.001) (Table 4, model 1).
On further adjustment with IScore, the associations did not change
(Table 4, model 2). The associations were not materially different
after adjustments for either individual inflammatory markers or the
combined IScore (data not shown). Similar patterns, but with slightly
stronger associations, were found in the subset with vitamin-D data
(n = 687) (Supplemental Table 3). We then assessed if inflammatory
score was independently associated with the glucose dysregulation
outcomes FPG, FI, HOMA-IR, and prevalent diabetes, and observed
significant associations (Q4 compared with Q1) for all outcomes
(Table 5). Finally, we assessed if inflammatory score was independently
associated with corrected serum calcium concentrations (Table 6), and
observed a significant interaction between IScore and sex, revealing a
positive association only in men.
Discussion
In this study, elevated corrected serum calcium concentrations
were significantly associated with markers of dysregulated glucose
metabolism (increased FI andHOMA-IR as well as FPG), and prevalent
type II diabetes, but not prevalent prediabetes, in a rural Indian
population after adjustment for all measured potential confounders.
When investigated in a subset with available data, these associations
were observed to be independent of endogenous regulators of calcium
metabolism, including serum phosphorus, creatinine, and vitamin D.
The findings were consistent, but slightly attenuated, after excluding
participants who used regular medication for hypertension that could
have altered calcium metabolism. Furthermore, we observed similar
patterns of associations in the subset of participants who had no self-
reported history of chronic disease and in whom inflammatorymarkers
were assessed. Inclusion of IScore in this subgroup as a measure of
chronic inflammationdid not alter the observedmeasures of association
between serum-corrected calcium and glucose dysregulation. However,
IScore was independently associated with markers of dysregulated
glucose metabolism in both sexes and with elevated serum calcium
concentrations, but only in men.
Our results are consistent with previous cross-sectional studies
in other populations. In South Korean adults aged ≥40 y, elevated
serum calcium was positively associated with type II diabetes and
metabolic syndrome (10). Although we did not find any evidence of
sex-specific associations for serum calcium and glucose dysregulation
in our study population, such associations have been observed in other
populations but not consistently. In a healthy Canadian population
significantly higher levels of FPG and HOMA-IR were observed in the
high-calcium group than in the low-calcium group, and this effect was
more evident in women than men (12). Conversely, in Japanese type
II diabetics significant positive correlations between serum calcium
and FPG and HOMA-IR were observed in men (11) but not in
women. A study on oral glucose intolerance in UK participants aged
40–65 y found 2-h plasma glucose to be positively associated with
total serum calcium and parathyroid hormone (PTH) both among
men and women. Cohort studies (5–9) conducted so far have mostly
confirmed temporal associations between elevated serum calcium and
incident type II diabetes. These associations, which have been reported
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TABLE 1 Participant characteristics1
Men Women P value2 Total
Number (%) 1291 (47.8) 1408 (52.2) 2699
Sociodemographic and socioeconomic
characteristics
Age, y 53.6 ± 7.0 47.3 ± 5.5 <0.0001 50.3 ± 7.0
Education, n (%)
No formal education 969 (75.1) 1342 (95.4) <0.001 2311 (85.7)
Primary school (up to class IV) 228 (17.7) 52 (3.7) — 280 (10.4)
Secondary school (class V–X/XII) 94 (7.3) 13 (0.9) — 107 (4.0)
Occupation, n (%)
Unemployed 76 (5.9) 260 (18.5) <0.001 336 (12.5)
Manual labour (skilled/unskilled) 1166 (90.4) 1139 (80.9) — 2305 (85.5)
Skilled nonmanual/semiprofessional 48 (3.7) 8 (0.6) — 56 (2.1)
SLI3 27.4 ± 8.1 26.9 ± 8.4 0.0966 27.1 ± 8.3
Urbanization4 (tertiles)
Low 467 (36.2) 513 (36.4) 0.893 980 (36.3)
Medium 397 (30.7) 441 (31.3) — 838 (31.0)
High 427 (33.1) 454 (32.2) — 881 (32.6)
Lifestyle characteristics, n (%)
Tobacco
Never 496 (38.4) 1048 (74.5) <0.001 1544 (57.2)
Current 753 (58.3) 350 (24.9) — 1103 (40.9)
Former 42 (3.2) 8 (0.6) — 50 (1.8)
Alcohol
Never 437 (33.8) 1073 (76.4) <0.001 1510 (56.0)
Daily/most days 98 (7.6) 5 (0.4) — 103 (3.8)
Weekends only 158 (12.2) 13 (0.9) — 171 (6.3)
Monthly 249 (19.3) 59 (4.2) — 308 (11.4)
Special occasions 349 (27.0) 255 (18.1) — 604 (22.4)
PAL
Extremely inactive 177 (14.8) 68 (5.2) <0.001 245 (9.8)
Sedentary 486 (40.7) 538 (41.4) — 1024 (41.1)
Moderately active 435 (36.5) 563 (43.3) — 998 (40.0)
Vigorously active 95 (8.0) 130 (10.0) — 225 (9.0)
Physical characteristics
BMI, kg/m2 20.5 ± 3.7 21.9 ± 4.2 <0.0001 21.2 ± 4.0
Waist circumference, cm 76.8 ± 10.5 73.4 ± 10.2 <0.0001 75.0 ± 10.5
Prevalent hypertension,5 n (%) 529 (41.0) 396 (28.1) <0.001 925 (34.3)
Regular medication for hypertension, n (%) 108 (11.5) 80 (7.0) <0.001 188 (9.0)
Prevalent prediabetes,5 n (%) 287 (25.0) 291 (23.1) 0.274 578 (24.0)
Prevalent diabetes,5 n (%) 122 (9.6) 103 (7.6) 0.060 225 (8.5)
Regular medication for diabetes, n (%) 51 (4.0) 46 (3.4) 0.383 97 (3.7)
Biochemical parameters
Corrected serum calcium,6 mg/dL 9.3 (8.9, 9.8) 9.3 (8.9, 9.7) 0.8051 9.3 (8.9, 9.7)
Serum calcium uncorrected, mg/dL 9.8 (9.3, 10.3) 9.7 (9.3, 10.3) 0.1550 9.7 (9.3, 10.3)
Serum phosphorus, mg/dL 4.0 ± 0.8 4.2 ± 0.8 <0.0001 4.1 ± 0.8
Serum vitamin D,7 ng/mL 19.2 ± 10.1 20.8 ± 8.0 0.0001 20.0 ± 9.1
Fasting plasma glucose, mg/dL 99.1 ± 27.8 97.9 ± 27.3 0.2884 98.5 ± 27.5
Fasting insulin (µU/ml) 3.0 (1.6, 5.9) 4.8 (3.0, 7.8) <0.0001 4.1 (2.3, 7.0)
HOMA-IR 0.7 (0.4, 1.4) 1.1 (0.7, 1.9) <0.0001 0.9 (0.5, 1.7)
Serum creatinine, mg/dL 0.9 ± 0.2 0.7 ± 0.1 <0.0001 0.8 ± 0.2
1Participants were rural Indian men and women aged 40–84 y (n = 2699) in the Andhra Pradesh Children and Parents Study (APCaPS, 2010–12). Values are n (%), means
± SDs, or median (IQR). FPG, fasting plasma glucose; PAL, physical activity level; SLI, Standard of Living Index.
2Pvalues are from t test, Wilcoxon rank-sum, or chi-square test for difference in means, medians, or proportions.
3Standardized score based on household assets.
4Based on composite score indicating degree of urbanization of the area.
5Hypertension: doctor-diagnosed disease, systolic blood pressure ≥140 mm Hg, or diastolic blood pressure ≥90 mm Hg at the time of the interview; diabetes: doctor-
diagnosed disease or FPG >126 mg/dL at the time of the interview; prediabetes: FPG = 100–125 mg/dL at the time of the interview.
6Total serum calcium corrected for albumin through the use of the formula: (serum calcium mg/dL) + [0.8 × (4 – serum albumin g/dL)].
7Data were available for 63.4% of participants (n = 1713/2699). Missing data for all other variables were <5% except for PAL (7.7%).
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TABLE 2 Distribution of population characteristics by quartiles of corrected serum calcium concentrations1
Quartiles of corrected serum calcium concentrations2
Q1 Q2 Q3 Q4 P value3
Serum calcium concentration, mg/dL 8.7 (8.5, 8.8) 9.1 (9.0, 9.2) 9.5 (9.3, 9.6) 10.1 (9.9, 10.5) —
Number 654 650 651 651 —
Sociodemographic and socioeconomic
characteristics
Age, y 50.1 ± 7.0 50.1 ± 7.1 50.4 ± 7.0 50.7 ± 7.0 0.34
Sex, n (%)
Men 329 (50.3) 302 (46.5) 302 (46.4) 327 (50.2) 0.28
Education, n (%)
No formal education 555 (84.9) 552 (84.9) 561 (86.2) 560 (86.2) 0.50
Primary school (up to class IV) 72 (11.0) 63 (9.7) 70 (10.8) 66 (10.2) —
Secondary school (class V–X/XII) 27 (4.1) 35 (5.4) 20 (3.1) 24 (3.7) —
Occupation, n (%)
Unemployed 60 (9.2) 89 (13.7) 96 (14.7) 76 (11.7) —
Manual labour 579 (88.5) 550 (84.6) 542 (83.3) 552 (86.1) —
Skilled nonmanual/semiprofessional 15 (2.3) 11 (1.7) 13 (2.0) 14 (2.2) 0.078
SLI4 26.8 ± 7.9 27.6 ± 8.3 27.9 ± 8.1 26.4 ± 8.7 0.003
Urbanization5 (tertiles)
Low 198 (30.3) 208 (32.0) 231 (35.5) 308 (47.3) <0.001
Medium 269 (41.1) 251 (38.6) 185 (28.4) 87 (13.4) —
High 187 (28.6) 197 (29.4) 235 (36.1) 256 (39.3) —
Lifestyle characteristics, n (%)
Tobacco
Never 378 (57.9) 385 (59.2) 360 (55.3) 365 (56.2) 0.48
Ever 275 (42.1) 265 (40.8) 291 (44.7) 285 (43.8) —
Alcohol
Never 346 (53.0) 389 (59.8) 353 (54.3) 357 (54.9) 0.12
Daily/weekly 70 (10.7) 50 (7.7) 71 (10.9) 74 (11.4) —
Monthly/special Occasions 237 (36.3) 211 (32.5) 226 (34.8) 219 (33.7) —
PAL
Extremely inactive 39 (7.1) 59 (10.1) 65 (10.3) 72 (11.3) 0.005
Sedentary 217 (39.7) 243 (41.4) 282 (44.8) 247 (38.6) —
Moderately active 249 (4.5) 235 (40.0) 232 (36.9) 244 (38.1) —
Vigorously active 42 (7.7) 50 (8.5) 50 (7.9) 77 (12.0) —
Physical characteristics
BMI, kg/m2 20.9 ± 3.7 21.3 ± 3.9 21.5 ± 4.3 21.2 ± 4.1 0.025
Waist circumference, cm 74.2 ± 10.1 75.2 ± 10.5 75.8 ± 10.8 75.1 ± 10.3 0.044
Prevalent hypertension,6 n (%) 200 (30.6) 216 (33.2) 240 (36.9) 234 (35.9) 0.071
Prevalent prediabetes,6 n (%) 137 (22.3) 136 (22.6) 164 (27.9) 132 (22.7) 0.071
Prevalent diabetes,6 n (%) 40 (6.1) 48 (7.4) 61 (9.4) 69 (10.6) 0.016
Biochemical parameters
Serum phosphorus, mg/dL 4.0 ± 1.2 4.0 ± 0.6 4.2 ± 0.6 4.4 ± 0.6 <0.001
Serum vitamin D,7 ng/mL 20.3 ± 10.2 19.9 ± 8.4 19.3 ± 8.4 20.5 ± 9.3 0.25
Fasting plasma glucose, mg/dL 95.7 ± 20.0 96.6 ± 24.3 100.6 ± 29.2 100.6 ± 33.1 <0.001
Fasting insulin, µU/mL 3.6 (2.1, 6.0) 3.8 (2.2, 6.8) 4.3 (2.5, 7.5) 4.5 (2.4, 7.8) <0.001
HOMA-IR score 0.8 (0.5, 1.4) 0.9 (0.5, 1.6) 1.0 (0.6, 1.9) 1.1 (0.5, 1.9) <0.001
Serum creatinine, mg/dL 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 0.9 ± 0.2 <0.001
1Participants were rural Indian men and women aged 40–84 y (n = 2699) in the Andhra Pradesh Children and Parents Study (APCaPS, 2010–12). Values are n (%), means
± SDs, or median (IQR). FPG, fasting plasma glucose; PAL, physical activity level; Q, quartile; SLI, Standard of Living Index.
2Total serum calcium corrected for albumin through the use of the formula: (calcium mg/dL) + [(0.8 × (4 – albumin g/dL)].
3P values are from ANOVA, Kruskal-Wallis ANOVA, or chi-square test for difference in means, medians or proportions.
4Standardized score based on household assets.
5Based on composite score indicating degree of urbanization of the area.
6Hypertension: doctor-diagnosed disease, a systolic blood pressure ≥140 mm Hg, or a diastolic blood pressure ≥90 mm Hg at the time of the interview; diabetes:
doctor-diagnosed disease or FPG >126 mg/dL at the time of the interview; prediabetes: FPG = 100–125 mg/dL at the time of the interview.
7Data were available for 63.4% of participants (n = 1713/2699). Missing data for all other variables were <5% except for PAL (7.7%).
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TABLE 3 Associations of corrected serum calcium concentrations with fasting plasma glucose, fasting insulin, insulin resistance,
prevalent prediabetes and diabetes1
Corrected serum calcium quartiles
FPG, mg/dL (β;
95% CI)
FI,2 µU/ml (β;
95% CI)
HOMA-IR2 (β;
95% CI)
Prevalent
prediabetes
(OR; 95% CI)
Prevalent
diabetes
(OR; 95% CI)
Model 1 n = 2605 n = 2604 n = 2603 n = 2385 n = 2605
Q1 0.00 (ref) 0.00 (ref) 0.00 (ref) 1.00 (ref) 1.00 (ref)
Q2 0.7 (−2.2, 3.6) 1.1 (1.0, 1.2) 1.1 (1.0, 1.3) 1.0 (0.8, 1.4) 1.2 (0.8, 1.8)
Q3 4.6 (1.6, 7.5) 1.3 (1.1, 1.4) 1.3 (1.2, 1.5) 1.3 (1.0, 1.8) 1.6 (1.0, 2.4)
Q4 4.6 (1.6, 7.6) 1.4 (1.3, 1.6) 1.5 (1.3, 1.6) 0.9 (0.7, 1.3) 1.9 (1.2, 2.9)
P-trend <0.001 <0.001 <0.001 0.749 0.001
Model 2 n = 2394 n = 2393 n = 2392 n = 2190 n = 2394
Q1 0.00 (ref) 0.00 (ref) 0.00 (ref) 1.00 (ref) 1.00 (ref)
Q2 −1.4 (−4.4, 1.6) 1.1 (1.0, 1.2) 1.1 (1.0, 1.2) 0.9 (0.7, 1.2) 0.9 (0.5, 1.5)
Q3 1.3 (−1.6, 4.3) 1.2 (1.1, 1.3) 1.2 (1.1, 1.3) 1.0 (0.8, 1.4) 1.1 (0.7, 1.8)
Q4 2.1 (−0.9, 5.2) 1.4 (1.2, 1.5) 1.4 (1.2, 1.5) 0.7 (0.5, 1.1) 1.6 (1.0, 2.6)
P-trend 0.058 <0.001 <0.001 0.206 0.020
P-interaction by sex3 0.6589 0.3144 0.2690 0.8267 0.4047
1Participants were rural Indian men and women aged 40–84 y from the Andhra Pradesh Children and Parents Study (APCAPS, 2010–12). Associations were determined by
multilevel random-effects linear (for FPG, FI and HOMA-IR) and logistic (for prediabetes and diabetes prevalence) regressionmodels. Median serum calcium concentrations
(mg/dL) corrected for albumin by quartiles: Q1 = 8.7 (IQR: 8.5, 8.8); Q2 = 9.1 (IQR: 9.0, 9.2); Q3 = 9.5 (IQR: 9.3, 9.6); Q4 = 10.1 (IQR: 9.9, 10.5). Model 1: adjusted for age
(y), sex, SLI (tertiles), urbanization score (tertiles). Model 2: adjusted for age (y), sex, SLI (tertiles), urbanization score (tertiles), tobacco (never/ever), alcohol (categories),
physical activity (categories), BMI (kg/m2), waist circumference (cm). FI, fasting insulin; FPG, fasting plasma glucose; Q, quartile; ref, reference; SLI, Standard of Living
Index.
2β coefficient and CI values were backtransformed (eβ ) as outcome variables and were natural log transformed before analyses.
3Likelihood-ratio test for interaction of sex with serum calcium quartiles.
across different populations, were also unaffected by endogenous
regulators of calcium metabolism including vitamin D, phosphorus,
magnesium, serum creatinine or glomerular filtration rate, as well as
PTH. However, a recent prospective study among southeast Asians
reported no association between serum calcium and incident type II
diabetes, but on the contrary reported higher dietary calcium to be
associated with a reduced risk of type II diabetes development (24).
Vitamin D and PTHmay also be independently involved in diabetes
risk (8, 25, 26). We did not have any information available on PTH,
a deficiency that limits our interpretation in terms of some residual
TABLE 4 Associations of corrected serum calcium concentrations with fasting plasma glucose, fasting insulin, insulin resistance
and prevalent prediabetes1
Corrected serum calcium quartiles
FPG, mg/dL (β;
95% CI)
FI,2 µU/mL (β;
95% CI)
HOMA-IR2 (β;
95% CI)
Prevalent
prediabetes
(OR; 95% CI)
Model 1 n = 917 n = 917 n = 917 n = 882
Q1 0.00 (ref) 0.00 (ref) 0.00 (ref) 1.00 (ref)
Q2 −1.6 (−5.2, 2.0) 1.0 (0.9, 1.2) 1.0 (0.9, 1.2) 0.8 (0.5, 1.4)
Q3 −0.13 (−3.8, 3.5) 1.1 (0.9, 1.2) 1.1 (0.9, 1.2) 1.0 (0.6, 1.7)
Q4 1.5 (−2.2, 5.2) 1.3 (1.2, 1.5) 1.3 (1.1, 1.5) 0.8 (0.5, 1.4)
P-trend 0.334 <0.001 <0.001 0.627
P-interaction by sex3 0.9972 0.0361 0.0634 0.7121
Model 2 n = 914 n = 914 n = 914 n = 879
Q1 0.00 (ref) 0.00 (ref) 0.00 (ref) 1.00 (ref)
Q2 −1.6 (−5.2, 2.0) 1.0 (0.9, 1.2) 1.0 (0.9, 1.2) 0.8 (0.5, 1.4)
Q3 −0.5 (−4.2, 3.1) 1.1 (0.9, 1.2) 1.1 (0.9, 1.2) 0.9 (0.5, 1.6)
Q4 0.7 (−3.0, 4.4) 1.3 (1.1, 1.5) 1.3 (1.1, 1.5) 0.7 (0.4, 1.3)
P-trend 0.613 <0.001 <0.001 0.368
P-interaction by sex3 0.9973 0.0467 0.0818 0.6351
P-interaction by IScore4 0.6647 0.6499 0.7164 0.6182
1Participants were a random sample of healthy rural Indian men and women aged 40–84 y (n= 1000) from the Andhra Pradesh Children and Parents Study (APCaPS, 2010–
12). Participants with a self-reported history of any chronic disease including hypertension, diabetes, cardiovascular disease, chronic obstructive respiratory disease, and
cancer were excluded. Associations were determined with multilevel random-effects linear (for FPG, FI and HOMA-IR) and logistic (for prevalent prediabetes) regression
models. Median serum calcium concentrations (mg/dL) corrected for albumin by quartiles: Q1 = 8.7 (IQR: 8.5, 8.8); Q2 = 9.1 (IQR: 9.0, 9.2); Q3 = 9.5 (IQR: 9.3, 9.6); Q4 =
10.1 (IQR: 9.9, 10.5). Model 1: adjusted for age (y), sex, SLI (tertiles), urbanization score (tertiles), tobacco (never/ever), alcohol (categories), physical activity (categories),
BMI (kg/m2), and waist circumference (cm); Model 2: Model 1 plus overall inflammatory score. FI, fasting insulin; FPG, fasting plasma glucose; IScore, inflammatory score;
Q, quartile; ref, reference; SLI, Standard of Living Index.
2β coefficient and CI values were back-transformed (eβ ) as outcome variables and were ln-transformed before analyses.
3Likelihood-ratio test for interaction of sex and serum calcium quartiles.
4Likelihood-ratio test for interaction of IScore and serum calcium quartiles [IScore was categorized as an anti-inflammatory score or a proinflammatory score based on
negative and positive values, respectively (21)].
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TABLE 5 Associations of inflammatory score with fasting plasma glucose, fasting insulin, insulin resistance and prevalent
prediabetes1
IScore quartiles2
FPG (mg/dL) (β;
95% CI)
(n = 913)
FI3 (µU/ml) (β;
95% CI)
(n = 913)
HOMA-IR3 (β;
95% CI)
(n = 913)
Prevalent
prediabetes
(OR; 95% CI)
(n = 878)
Q1 Ref Ref Ref Ref
Q2 0.01 (−0.01, 0.04) 1.1 (1.01, 1.3) 1.1 (1.01, 1.3) 1.5 (0.9, 2.8)
Q3 0.02 (−0.006, 0.05) 1.08 (0.96, 1.2) 1.1 (0.96, 1.2) 1.2 (0.6, 2.1)
Q4 0.07 (0.04, 0.1) 1.3 (1.1, 1.5) 1.4 (1.2, 1.6) 2.8 (1.5, 5.4)
P-trend <0.001 0.001 <0.001 0.003
P-interaction by sex4 0.2701 0.7967 0.7707 0.1256
1Participants were a random sample of healthy rural Indian men and women aged 40–84 y (n = 1000) from the Andhra Pradesh Children and Parents Study (APCaPS,
2010–12). Participants with a self-reported history of any chronic disease including hypertension, diabetes, cardiovascular disease, chronic obstructive respiratory disease,
and cancer were excluded. Associations were adjusted for age (years), sex, SLI (tertiles), urbanization score (tertiles), tobacco (never/ever), alcohol (categories), physical
activity (categories), BMI (kg/m2), waist circumference (cm), serum calcium (mg/dL), serum phosphorus (mg/dL), and serum creatinine (mg/dL) with a random-effects
linear/logistic multilevel model. CRP, C-reactive protein; FI, fasting insulin; FPG, fasting plasma glucose; IScore, inflammatory score; Q, quartile; Ref, reference; sICAM-1,
soluble intercellular adhesion molecule 1; SLI, Standard of Living Index.
2IScore was calculated by summing the z scores of markers to create a standardized overall inflammatory marker score for each participant as follows: [(z score IL-6) + (z
score CRP) + (z score IL-18) + (z score sICAM-1)] – (z score adiponectin) (21).
3 β coefficient and CI values were back-transformed (eβ ) as outcome variables and were ln-transformed before analyses.
4Likelihood-ratio test for interaction of sex and inflammatory score quartiles.
confounding. However, the dose-response association (Q4 compared
with Q1) was consistent in the overall study population as well as across
several subsets within the study population (i.e., a healthy subset, a
subset excluding participants with regular hypertensivemedication use,
as well as a subset with vitamin D data). The associations with markers
of dysregulated glucose metabolism and prevalent type II diabetes were
strengthened in the subset with vitamin D data. This subset included
young men and women living in locations with higher urbanization
scores and low SLIs. This might have been a chance finding due to the
relatively smaller sample size but could possibly be indicating high-risk
individuals within this population.
The probable causal role of elevated serum calcium for type II
diabetes is becoming established through cohort studies and consis-
tent cross-sectional findings across different populations worldwide
(4–13, 27). Randomized clinical trials report that calcium-channel
blockers or other medications prevent or stabilize type II diabetes
compared with the use of diuretics in patients with other disease
conditions including hypertension (14, 28).
The proposed mechanisms for the associations of elevated serum
calcium on glucose metabolism dysregulation include the role of
calcium in reducing the function of glucose transporters on adipocytes
(15), altering β cell function, and increasing insulin resistance. Serum
calcium concentrations could be elevated by underlying chronic low
levels of inflammation (4, 27). Inflammation and elevated calcium
could synergistically contribute to organelle dysfunction and damage,
leading to dysregulated glucose metabolism (4, 27). In our study,
chronic inflammation did not appear to mediate associations between
serum calcium and dysregulated glucose metabolism. Inadequate
measurement of inflammation could have influenced these associations.
However, although we did not have information on TNF-α and
IL-10, important pro- and anti-inflammatory markers, respectively
(29), the use of a composite inflammatory score has been shown
previously to adequately characterize the overall inflammatory status
of the participants (21). The role of chronic inflammation in the
pathogenesis of type II diabetes is well established, (4, 27). We
found independent positive associations of chronic inflammation with
TABLE 6 Associations of inflammatory score with corrected serum calcium concentrations1
Corrected serum calcium concentration (β; 95% CI)
IScore quartiles2 Overall (n = 914) Men (n = 461) Women (n = 453)
Q1 Ref Ref Ref
Q2 0.09 (−0.02, 0.2) 0.3 (0.1, 0.5) −0.07 (−0.2, 0.09)
Q3 0.1 (0.02, 0.2) 0.3 (0.2, 0.5) −0.07 (−0.2, 0.1)
Q4 0.2 (0.1, 0.4) 0.4 (0.2, 0.6) 0.2 (−0.01, 0.3)
P-trend <0.001 <0.001 0.113
P-interaction by sex3 0.0258 — —
1Participants were a random sample of healthy rural Indian men and women aged 40–84 y (n = 1000) from the Andhra Pradesh Children and Parents Study (APCaPS,
2010–12). Participants with a self-reported history of any chronic disease including hypertension, diabetes, cardiovascular disease, chronic obstructive respiratory disease,
and cancer were excluded. Association were adjusted for age (y), sex, SLI (tertiles), urbanization score (tertiles), tobacco (never/ever), alcohol (categories), physical activity
(categories), BMI (kg/m2), and waist circumference (cm) through the use of a random-effects linear multilevel model. The associations followed a similar pattern when
adjusted for serum concentrations of phosphorous, creatinine and vitamin D in a subset with vitamin D data (n = 618). CRP, C-reactive protein; FI, fasting insulin; FPG,
fasting plasma glucose; SLI, Standard of Living Index; IScore, inflammatory score; Q, quartile; Ref, reference; sICAM-1, soluble intercellular adhesion molecule 1.
2IScore was calculated summing the z scores of markers to create a standardized overall inflammatory marker score for each participant as follows: [(z score IL-6) + (z
score CRP) + (z score IL-18) + (z score sICAM-1)] – (z score adiponectin) (21).
3Likelihood-ratio test for interaction of sex and inflammatory score quartiles.
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markers of dysregulated glucose metabolism in the healthy subset of
participants, consistent with the existing evidence.
There is a large body of preclinical data (in vitro and animal
models) on the elevation of serum calcium concentrations by chronic
inflammation (4, 27). We found positive associations of chronic inflam-
mation (IScore) with elevated corrected serum calcium among men,
indicating a role for chronic inflammation in elevating serum calcium
concentrations. We did not find similar associations among women,
suggesting that the factors for elevated serum calcium in women could
be other than inflammation. Similar sex-specific differences have been
observed with coronary artery calcium deposition and inflammatory
markers wherein adiponectin was found to be inversely associated
(30) and hsCRP positively associated with coronary artery calcium
in men (31) but not among women. It has been established that
inflammatory responses and their influence on various chronic diseases,
including type II diabetes, are gender specific due to sex hormones,
genetic factors, and differences in lifestyle risk exposures (28), but
further investigations are required to understand the mechanisms
better. Inadequate measurement of inflammatory markers specific for
women, such as IFN-γ and IL-10 (28), could also have influenced these
associations; however, this is less likely as chronic inflammation was
associated with markers of dysregulated glucose metabolism.
Our results suggest that chronic inflammation may not be on the
causal pathway between serum calcium and glucose dysregulation in
our study population, but it remains possible that it may be involved
in early elevation of serum calcium concentrations among men. In this
population, serum calcium concentrations and chronic inflammation
are associated with glucose metabolism but act independently of
each other. Cautious interpretation of these results is required for
the following reasons: 1) the inherent limitations of a cross-sectional
study design such as reverse causation and temporality; 2) the
potential measurement error of chronic inflammation, although the
inflammatory markers used in our study were among the markers most
commonly used to examine disease endpoints, have been validated for
calculating inflammatory scores in other populations (21), and were
previously associated with calcium and glucose metabolism (4, 27,
30, 31); and 3) the association between elevated serum calcium and
prevalent prediabetes was not evident in this population.
Despite these limitations, this study possesses considerable merits.
This was a rural Indian population-based study with an adequate
sample size to test the dose response. The dose-response results for
the association of elevated serum calcium with markers of dysregulated
glucose metabolism and type II diabetes were stable across different
subsets. Our results are in line with scientific evidence available
to date and are biologically plausible. Furthermore, we observed
independent associations of chronic inflammation with dysregulated
glucose metabolism and serum calcium concentrations. To the best of
our knowledge, this is the first report of the associations of elevated
serum calcium concentrations and chronic inflammation on markers
of glucose metabolism dysregulation, evaluating them as independent
risk factors, confounders, andmediators in a representative rural Indian
population.
In conclusion, consistent with previous observational studies,
elevated serum calcium is positively associated with markers of
dysregulated glucose metabolism and prevalent type II diabetes in a
rural Indian population. This association was not mediated through
chronic inflammation, but chronic inflammation was independently
associated with glucose metabolism dysregulation. It remains possible
that inflammation might be responsible for elevation of serum calcium
early in the pathway, but only among men. Large-scale, population-
based studies to validate these findings, and clinical studies to address
their clinical relevance and understand potential sex-specific effects are
recommended.
Acknowledgments
The authors’ contributions were as follows—KS, PKD, SEC: designed
the research; S Kinra, PKD, RG, S Khandelwal, and DP: conducted the
research; KS: analyzed the data; KS and SEC: wrote the first draft of the
paper; all authors: had primary responsibility for final content; and all
authors: read and approved the final manuscript.
References
1. GBD 2016 Causes of Death Collaborators. Global, regional, and national
age-sex specific mortality for 264 causes of death, 1980–2016: a systematic
analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:
1151–210.
2. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national
disability-adjusted life-years (DALYs) for 333 diseases and injuries and
healthy life expectancy (HALE) for 195 countries and territories,1990–2016:
a systematic analysis for the Global Burden of Disease Study 2016. Lancet
2017; 390: 1260–344.
3. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY.
Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681–88
4. Arruda AP, Hotamisligil GS. Calcium homeostasis and organelle function
in the pathogenesis of obesity and diabetes. Cell Metab 2015; 22(3): 381–97.
5. Jorde R, Schirmer H, Njølstad I, Løchen M, Mathiesen EB, Kamycheva E,
Figenschau Y, Grimnes G. Serum calcium and the calcium-sensing
receptor polymorphism rs17251221 in relation to coronary heart disease,
type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol
2013; 28:569–78.
6. Lorenzo C, Hanley AJ, Rewers MJ, Haffner SM. Calcium and phosphate
concentrations and future development of type 2 diabetes: the Insulin
Resistance Atherosclerosis Study. Diabetologia 2014; 57:1366–74.
7. Becerra-Tomás N, Estruch R, Bulló M, Casas R, Díaz-López A, Basora J,
Fitó M, Serra-Majem L, Salas-Salvadó J. Increased serum calcium levels
and risk of type 2 diabetes in individuals at high cardiovascular risk.
Diabetes Care 2014; 37:3084–91.
8. Suh S, Bae JC, Jin SM, Jee JH, Park MK, Kim DK, Kim JH. Serum calcium
changes and risk of type 2 diabetes mellitus in Asian population. Diabetes
Res Clin Pract. 2017 Nov;133:109–14.
9. Rooney MR, Pankow JS, Sibley SD, Selvin E, Reis JP, Michos ED, Lutsey
PL. Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in
Communities (ARIC) study. Am J Clin Nutr 2016; 104:1023–9.
10. Kim MK, Kim G, Jang E, Kwon H, Baek K, Oh K, Lee J, Yoon K-H, Lee W,
Lee K, et al. Altered calcium homeostasis is correlated with the presence of
metabolic syndrome and diabetes in middle-aged and elderly Korean
subjects: the Chungju Metabolic Disease Cohort study (CMC study).
Atherosclerosis 2010; 212:674–81.
11. Yamaguchi T, Kanazawa I, Takaoka S, Sugimoto T. Serum calcium is
positively correlated with fasting plasma glucose and insulin resistance,
independent of parathyroid hormone, in male patients with type 2 diabetes
mellitus. Metabolism 2011; 60:1334–9.
12. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium
homeostasis is correlated with abnormalities of fasting serum glucose,
insulin resistance, and b-cell function in the Newfoundland population.
Diabetes 2005; 54:3336–9.
CURRENT DEVELOPMENTS IN NUTRITION
10 Shridhar et al.
13. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN. Glucose
intolerance is associated with altered calcium homeostasis: a possible link
between increased serum calcium concentration and cardiovascular disease
mortality. Metabolism 1997; 46:1171–7.
14. Lopez-Candales A, Hernández Burgos PM, Hernandez-Suarez DF, Harris
D. Linking chronic inflammation with cardiovascular disease: from normal
aging to the metabolic syndrome. J Nat Sci. 2017; 3(4). pii:
e341.
15. Chatterjee R, Lin PH. Serum calcium and its complex association with
incident type 2 diabetes. Am J Clin Nutr 2016; 104:957–8.
16. Ramachandran A, Wan Ma RC, Snehalatha C. Diabetes in Asia. Lancet
2010; 375: 408–18.
17. Kinra S, Krishna KVR, Kuper H, Sarma KVR, Prabhakaran P, Gupta V,
Walia GK, Bhogadi S, Kulkarni B, Kumar A, et al. Cohort profile: Andhra
Pradesh Children and Parents Study (APCAPS). Int J Epidemiol 2014;
43:1417–24.
18. Macro IIfPSIaO. National Family Health Survey (NFHS-2), 1998–99: India.
Mumbai: IIPS; 2000. Available at dhsprogram.com/pubs/pdf/frind2/frind2.
pdf. Accessed on 1 September, 2017.
19. Matsuzaki M, Sullivan R, Ekelund U, Krishna KV, Kulkarni B, Collier T,
Ben-Shlomo Y, Kinra S, Kuper H. Development and evaluation of the
Andhra Pradesh Children and Parent Study Physical Activity Questionnaire
(APCAPS-PAQ): a cross-sectional study. BMC Public Health. 2016; 16:
48.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner
RC. Homeostasis model assessment: insulin resistance and beta-cell
function from fasting plasma glucose and insulin concentrations in man.
Diabetologia 1985; 28: 412e9.
21. Tabung FK, Smith-Warner SA, Chavarro JE, Wu K, Fuchs CS, Hu FB,
Chan AT, Willett WC, Giovannucci EL. Development and validation of an
empirical dietary inflammatory index. J Nutr 2016; 146: 1560–
70.
22. Baron RM, Kenny DA. The moderator-mediator variable distinction in
social psychological research: conceptual, strategic, and statistical
considerations. J Pers Soc psychol. 1986; 51(6):1173–82.
23. Napolitano MA, Papandonatos GD, Lewis BA, Whiteley JA, Williams DM,
King AC, Bock BC, Pinto B, Marcus BH. Mediators of physical activity
behavior change: a multivariate approach. Health Psychol. 2008;
27(4):409–18.
24. Kim KN, Oh SY, Hong YC. Associations of serum calcium levels and
dietary calcium intake with incident type 2 diabetes over 10 years: the
Korean Genome and Epidemiology Study (KoGES). Diabetol Metab Syndr.
2018;10:50
25. Xuan Y, Zhao H-y, Liu J-M. Vitamin-D and type-II diabetes mellitus. J
Diabetes 2013;5: 261–7.
26. Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North
Am 2014; 43: 205–32.
27. Ramadan JW, Steiner SR, O’Neill MC, Nunemaker CS. The central role of
calcium in the effects of cytokines on betacell function: implications for
type 1 and type 2 diabetes. Cell Calcium. 2011; 50(6): 481–90.
28. Abuissa H, Jones PG, Marso SP, O’Keefe JH Jr. Angiotensin-converting
enzyme inhibitors or angiotensin receptor blockers for prevention of type 2
diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol.
2005; 46:821–6.
29. Gubbels Bupp MR. Sex, the aging immune system, and chronic disease. Cell
Immunol. 2015;294(2):102–10.
30. Larsen BA, Laughlin GA, Cummins K, Barrett-Connor E, Wassel CL.
Adipokines and severity and progression of coronary artery calcium:
Findings from the Rancho Bernardo Study. Atherosclerosis. 2017
Oct;265:1–6.
31. Lin A, Lacy ME, Eaton C, Correa A, WuWC. Inflammatory obesity
phenotypes, gender effects, and subclinical atherosclerosis in african
americans: the Jackson Heart Study. Arterioscler Thromb Vasc Biol. 2016
Dec;36(12):2431–8.
CURRENT DEVELOPMENTS IN NUTRITION
